Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Feasibility Study of the Velocity™ Percutaneous Arterio-Venous Fistula System

NCT06712251 is registered in ClinicalTrials.gov with Venova Medical as lead sponsor.

NCT NCT06712251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06712251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Feasibility Study of the Velocity™ Percutaneous Arterio-Venous Fistula System
Lead sponsor
Venova Medical
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 8, 2025
Completion date
January 4, 2027
Enrollment
20 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease requiring hemodialysis, end stage renal disease (esrd)